James R. Largent - 04 Jan 2023 Form 4 Insider Report for ALIMERA SCIENCES INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 04 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jan 2023, 16:00:44 UTC
Prior SEC filing: 04 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ James R. Largent

Key filing fact

James R. Largent filed Form 4 for ALIMERA SCIENCES INC on 06 Jan 2023.

Key facts

This page summarizes James R. Largent's Form 4 filing for ALIMERA SCIENCES INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jan 2023, 16:00.

Change

Previous filing in this sequence was filed on 04 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALIM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +6,000
Change %
Price: $0.000000
Shares after: 6,000
Date: 04 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,000
Exercise price: $2.72
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date.